Tumor Contamination of Stem Cell Products
作者： John G. Gribben
DOI: 10.1007/978-1-59259-733-8_19
关键词:
摘要: Despite the success of use combination chemotherapy for treatment advanced-stage malignancies, majority these patients die their disease. In an attempt to overcome drug resistance, there has been increasing high-dose therapy (HDT) with a curative both in previously relapsed disease and increasingly as consolidation first complete remission. The myeloablation induced by HDT can be reversed autologous or allogeneic hematopoietic cell transplantation (autoHCT alloHCT, respectively). Autologous cells have several potential advantages over HCT. HCT overcomes need human leukocyte antigen (HLA)-identical donor, eliminates risk graft-vs-host-disease (GVHD) has, therefore, enabled dose escalation large number hematologic solid tumors (1–4).
springer.com
sci-hub.st 参考文章(58)
J R Berenson, G J Schiller, J Shin, A Kim, R A Vescio, A K Lichtenstein, J Cao, C H Wu, J C Lee, E J Han, Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts. Bone Marrow Transplantation. ,vol. 18, pp. 103- 110 ,(1996)
AA Ross, BW Cooper, HM Lazarus, W Mackay, TJ Moss, N Ciobanu, MS Tallman, MJ Kennedy, NE Davidson, D Sweet, Detection and Viability of Tumor Cells in Peripheral Blood Stem Cell Collections From Breast Cancer Patients Using Immunocytochemical and Clonogenic Assay Techniques Blood. ,vol. 82, pp. 2605- 2610 ,(1993) , 10.1182/BLOOD.V82.9.2605.BLOODJOURNAL8292605
RC Stong, F Uckun, RJ Youle, JH Kersey, DA Vallera, Use of Multiple T Cell-Directed Intact Ricin Immunotoxins for Autologous Bone Marrow Transplantation Blood. ,vol. 66, pp. 627- 635 ,(1985) , 10.1182/BLOOD.V66.3.627.627
D Benjamin, IT Magrath, EC Douglass, LM Corash, Derivation of lymphoma cell lines from microscopically normal bone marrow in patients with undifferentiated lymphomas: evidence of occult bone marrow involvement Blood. ,vol. 61, pp. 1017- 1019 ,(1983) , 10.1182/BLOOD.V61.5.1017.1017
Pap Sa, Bernal Sd, Elias Ad, Purging of small cell lung cancer-contaminated bone marrow by monoclonal antibodies and magnetic beads. Progress in Clinical and Biological Research. ,vol. 333, pp. 263- ,(1990)
JG Gribben, L Saporito, M Barber, KW Blake, RM Edwards, JD Griffin, AS Freedman, LM Nadler, Bone marrows of non-Hodgkin's lymphoma patients with a bcl-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells using monoclonal antibodies and immunomagnetic bead depletion Blood. ,vol. 80, pp. 1083- 1089 ,(1992) , 10.1182/BLOOD.V80.4.1083.1083
AL Billett, E Kornmehl, NJ Tarbell, HJ Weinstein, RD Gelber, J Ritz, SE Sallan, Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia Blood. ,vol. 81, pp. 1651- 1657 ,(1993) , 10.1182/BLOOD.V81.6.1651.1651
FW Preijers, T De Witte, JM Wessels, GC De Gast, E Van Leeuwen, PJ Capel, C Haanen, Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma. Blood. ,vol. 74, pp. 1152- 1158 ,(1989) , 10.1182/BLOOD.V74.3.1152.1152
Arnold S. Freedman, Donna Neuberg, Peter Mauch, Robert J. Soiffer, Kenneth C. Anderson, David C. Fisher, Robert Schlossman, Edwin P. Alyea, Tak Takvorian, Haddy Jallow, Caroline Kuhlman, Jerome Ritz, Lee M. Nadler, John G. Gribben, Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma Blood. ,vol. 94, pp. 3325- 3333 ,(1999) , 10.1182/BLOOD.V94.10.3325.422K13_3325_3333
MJ Robertson, RJ Soiffer, AS Freedman, SL Rabinowe, KC Anderson, TJ Ervin, C Murray, K Dear, JD Griffin, LM Nadler, Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis: clinical trial of MY9 monoclonal antibody-purged autografts for the treatment of acute myeloid leukemia. Blood. ,vol. 79, pp. 2229- 2236 ,(1992) , 10.1182/BLOOD.V79.9.2229.2229